Syngene International
SYNGENE
Syngene International Market Sentiment
| Timeline | Returns | Volume |
|---|---|---|
| Daily | -1.55% | 30,45,447 |
| Weekly | 3.18% | 44,69,459 |
| Monthly | 9.88% | 1,28,75,570 |
Syngene International Performance
| Timeline | Daily | Weekly | Monthly |
|---|---|---|---|
| SYNGENE | -1.55% | 3.18% | 9.88% |
| Index | - | - | - |
| Peer Avg. | 0.54% | 5.04% | 8.47% |
Syngene International Fundamentals
| Timeline | PE | PB | EV/EBIDTA | ROE | ROCE | Div. Yield |
|---|---|---|---|---|---|---|
| SYNGENE | 60.60 | 7.46 | 28.01 | 13.27 | 13.21 | 0.16 |
| Index | 36.20 | 6.77 | 17.25 | 17.89 | 19.69 | 1.20 |
| Peer Avg. | 101.21 | 6.27 | 22.63 | 9.32 | 10.21 | 0.25 |
Syngene International Key Metrics
| Metrics | Sales Growth | Profit Growth | ROE | ROCE |
|---|---|---|---|---|
| FY '21-22 | 19.29% | -2.35% | 13.27% | 13.21% |
| FY '20-21 | 8.45% | -1.82% | 16.57% | 15.37% |
| FY '19-20 | 10.20% | 24.35% | 20.21% | 19.59% |
Syngene International Shareholding Pattern
Syngene International Profit & Loss
| Metrics | Sales | Expenditure | EBITDA | PAT |
|---|---|---|---|---|
| FY '21-22 | 2,602.80 | 1,863.65 | 847.55 | 394.80 |
| FY '20-21 | 2,181.85 | 1,529.65 | 735.50 | 404.30 |
| FY '19-20 | 2,011.90 | 1,409.10 | 698.90 | 411.80 |
Syngene International Share Price
Syngene International Limited is an integrated research, development and manufacturing service company operating in India. The company provides contract research and manufacturing services from lead generation to clinical supply to pharmaceutical and biotechnology companies worldwide. Its services include drug discovery and development capabilities in medicinal chemistry, biology, in vivo pharmacology, toxicology, custom synthesis, process research and development, current good manufacturing practice (cGMP) production, formulation and analytical development, and clinical development services. It offers SynVent, a therapeutic discovery and development platform for drug development projects. SynVent's portfolio spans categories and therapeutic areas from small molecule inhibitors to targeted protein stabilisation. It serves the pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical industries.